1. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999; 353: 1959-1964. PMID:
10371588.
2. Ro LS, Chang KH. Neuropathic pain: mechanisms and treatments. Chang Gung Med J 2005; 28: 597-605. PMID:
16323550.
3. Haythornthwaite JA, Benrud-Larson LM. Psychological aspects of neuropathic pain. Clin J Pain 2000; 16(2):Suppl. S101-S105. PMID:
10870748.
4. Waxman EA, Lynch DR. N-methyl-D-aspartate receptor subtype mediated bidirectional control of p38 mitogen-activated protein kinase. J Biol Chem 2005; 280: 29322-29333. PMID:
15967799.
5. Crown ED, Ye Z, Johnson KM, Xu GY, McAdoo DJ, Hulsebosch CE. Increases in the activated forms of ERK 1/2, p38 MAPK, and CREB are correlated with the expression of at-level mechanical allodynia following spinal cord injury. Exp Neurol 2006; 199: 397-407. PMID:
16478624.
6. Xu JT, Xin WJ, Wei XH, Wu CY, Ge YX, Liu YL, et al. p38 activation in uninjured primary afferent neurons and in spinal microglia contributes to the development of neuropathic pain induced by selective motor fiber injury. Exp Neurol 2007; 204: 355-365. PMID:
17258708.
7. Ji RR, Gereau RW 4th, Malcangio M, Strichartz GR. MAP kinase and pain. Brain Res Rev 2009; 60: 135-148. PMID:
19150373.
8. Joo JD, Choi JW, In JH, Jung HS, Lee JA, Kim YS, et al. Lidocaine suppresses the increased extracellular signal-regulated kinase/cyclic AMP response element-binding protein pathway and pro-inflammatory cytokines in a neuropathic pain model of rats. Eur J Anaesthesiol 2011; 28: 106-111. PMID:
21374892.
9. Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992; 50: 355-363. PMID:
1333581.
10. Dubé GR, Kohlhaas KL, Rueter LE, Surowy CS, Meyer MD, Briggs CA. Loss of functional neuronal nicotinic receptors in dorsal root ganglion neurons in a rat model of neuropathic pain. Neurosci Lett 2005; 376: 29-34. PMID:
15694269.
11. Houghton AK, Parsons CG, Headley PM. Mrz 2/579, a fast kinetic NMDA channel blocker, reduces the development of morphine tolerance in awake rats. Pain 2001; 91: 201-207. PMID:
11275375.
12. Lee HT, Krichevsky IE, Xu H, Ota-Setlik A, D'Agati VD, Emala CW. Local anesthetics worsen renal function after ischemia-reperfusion injury in rats. Am J Physiol Renal Physiol 2004; 286: F111-F119. PMID:
14519592.
13. Joo JD, Kim M, D'Agati VD, Lee HT. Ischemic preconditioning provides both acute and delayed protection against renal ischemia and reperfusion injury in mice. J Am Soc Nephrol 2006; 17: 3115-3123. PMID:
16988058.
14. Gallos G, Jones DR, Nasr SH, Emala CW, Lee HT. Local anesthetics reduce mortality and protect against renal and hepatic dysfunction in murine septic peritonitis. Anesthesiology 2004; 101: 902-911. PMID:
15448523.
15. Baron R. Peripheral neuropathic pain: from mechanisms to symptoms. Clin J Pain 2000; 16(2):Suppl. S12-S20. PMID:
10870735.
16. Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 2010; 9: 807-819. PMID:
20650402.
17. Kawamata M, Omote K. Involvement of increased excitatory amino acids and intracellular Ca
2+ concentration in the spinal dorsal horn in an animal model of neuropathic pain. Pain 1996; 68: 85-96. PMID:
9252003.
18. Szegedi V, Juhász G, Zhang X, Barkóczi B, Qi H, Madeira A, et al. Tianeptine potentiates AMPA receptors by activating CaMKII and PKA via the p38, p42/44 MAPK and JNK pathways. Neurochem Int 2011; 59: 1109-1122. PMID:
22056552.
19. Choi JW, In JH, Kim YS, Kang YJ, Lim YG, Cho SM, et al. Low dose ketamine reduces the induction of ERK1/2 and CREB signaling protein in a neuropathic pain model of rats. Korean J Anesthesiol 2009; 57: 210-216.
20. Gwak YS, Hulsebosch CE. Upregulation of Group I metabotropic glutamate receptors in neurons and astrocytes in the dorsal horn following spinal cord injury. Exp Neurol 2005; 195: 236-243. PMID:
16004983.
21. Mao L, Wang JQ. Interactions between ionotropic and metabotropic glutamate receptors regulate cAMP response element-binding protein phosphorylation in cultured striatal neurons. Neuroscience 2002; 115: 395-402. PMID:
12421605.
22. Yoshii A, Constantine-Paton M. BDNF induces transport of PSD-95 to dendrites through PI3K-AKT signaling after NMDA receptor activation. Nat Neurosci 2007; 10: 702-711. PMID:
17515902.
23. Labombarda F, Coronel MF, Villar MJ, Nicola AF, González SL. Neuropathic pain and temporal expression of preprodynorphin, protein kinase C and N-methyl-d-aspartate receptor subunits after spinal cord injury. Neurosci Lett 2008; 447: 115-119. PMID:
18835424.
24. Moon JY, Roh DH, Yoon SY, Kang SY, Choi SR, Kwon SG, et al. Sigma-1 receptor-mediated increase in spinal p38 MAPK phosphorylation leads to the induction of mechanical allodynia in mice and neuropathic rats. Exp Neurol 2013; 247: 383-391. PMID:
23333567.
25. Garry EM, Delaney A, Blackburn-Munro G, Dickinson T, Moss A, Nakalembe I, et al. Activation of p38 and p42/44 MAP kinase in neuropathic pain: involvement of VPAC2 and NK2 receptors and mediation by spinal glia. Mol Cell Neurosci 2005; 30: 523-537. PMID:
16202621.
26. Mao J, Price DD, Mayer DJ. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 1995; 61: 353-364. PMID:
7478678.
27. Wagley Y, Hwang CK, Lin HY, Kam AF, Law PY, Loh HH, et al. Inhibition of c-Jun NH2-terminal kinase stimulates mu opioid receptor expression via p38 MAPK-mediated nuclear NF-κB activation in neuronal and non-neuronal cells. Biochim Biophys Acta 2013; 1833: 1476-1488. PMID:
23485395.
28. Warncke T, Stubhaug A, Jørum E. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, crossover comparison with morphine and placebo. Pain 1997; 72: 99-106. PMID:
9272793.
29. Schnoebel R, Wolff M, Peters SC, Bräu ME, Scholz A, Hempelmann G, et al. Ketamine impairs excitability in superficial dorsal horn neurones by blocking sodium and voltage-gated potassium currents. Br J Pharmacol 2005; 146: 826-833. PMID:
16151436.
30. Ostenfeld T, Krishen A, Lai RY, Bullman J, Baines AJ, Green J, et al. Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double-blind, placebo-controlled study. Eur J Pain 2013; 17: 844-857. PMID:
23239139.